Following the outperformance of Cohen & Steers, Inc. CNS shares in 2016 to date, along with the stock’s higher relative valuation, Credit Suisse’s Ari Ghosh prefers to remain on the sidelines until there is a more attractive entry point into the stock.
Ghosh initiated coverage of Cohen & Steers with a Neutral rating and price target of $42.
Organic Growth
“While the combination of CNS's strong long-term fund performance and its in-favor product offering should generate positive organic growth through 2017, we actually expect CNS's organic growth rate to decline from current levels, which is tracking at +14 percent in 1H16,” the analyst mentioned.
In addition, Ghosh expects large AuUM/fund distribution to continue to offset robust inflows and weigh on total AUM growth for the company.
Position Outside The U.S.
The company generates about 20 percent of its revenues from non-U.S. clients, with a strong presence in Japan, where it is key sub-advisor for Daiwa.
“A foothold in a large strategic, low interest rate market like Japan, where investors are starved for yield, should help drive flows into CNS's income-focused products,” Ghosh added.
Did you like this article? Could it have been improved? Please email feedback@benzinga.com to let us know!
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.